Subscribe to RSS
DOI: 10.1055/s-0035-1545274
Consequences of the Chicago DSD Consensus: A Personal Perspective
Publication History
received 25 November 2014
accepted 15 January 2015
Publication Date:
06 March 2015 (online)
![](https://www.thieme-connect.de/media/hmr/201505/lookinside/thumbnails/2014-11-0354_10-1055-s-0035-1545274-1.jpg)
Abstract
A decade has passed since the Chicago Consensus meeting was convened to consider how to improve the management of individuals and their families with an intersex disorder. It is apposite to review, from an individual perspective, what impact the Consensus has had on clinical practice and research. Emphasis is placed on nomenclature and DSD classification, multidisciplinary team working, striving to reach a causative diagnosis for DSD, the value of uniformity of collective case registries for rare conditions, and the potential for meaningful clinical outcome studies and basic scientific research. The impact of the Consensus can be gauged objectively by an exponential increase in DSD-related publications in the medical and scientific literature and organisation of numerous national and international meetings. Psychologists and social scientists have embraced the subject area and enhanced the holistic approach to management of DSD. Much needs to be done to improve diagnosis, and to identify measures to predict outcome that can be used both in sex assignment decision-making and to improve the quality of life for young adults with DSD. Though challenging, these goals are attainable through specialist multidisciplinary clinics working at local level and the DSD community at large, collaborating at national and international levels to tap the data resources now being developed.
-
References
- 1 Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child 2006; 91: 554-563
- 2 Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. Pediatrics 2006; 118: e488-e500
- 3 Federman DD. Abnormal sexual development. Philadelphia: WB Saunders; 1967: 1-206
- 4 Pasterski V, Prentice P, Hughes IA. Consequences of the Chicago consensus on disorders of sex development (DSD): current practices in Europe. Arch Dis Child 2010; 95: 618-623
- 5 Davies JH, Knight EJ, Savage A, Brown J, Malone PS. Evaluation of terminology used to describe disorders of sex development. J Pediatr Urol 7: 412-415
- 6 Hughes IA. A quiet revolution. Best Pract Res Clin Endocrinol Metab 2010; 24: 159-162
- 7 Reis E. Divergence or disorder? The politics of naming intersex. Pers Biol Med 2007; 50: 535-543
- 8 Diamond M. Clinical implications of the organizational and activational effects of hormones. Horm Behav 2009; 55: 621-632
- 9 Guntram L. Differently normal and normally different: negotiations of female embodiment in women’s accounts of atypical sex development. Soc Sci Med 2013; 98: 232-238
- 10 Brain CE, Creighton SM, Mushtaq I, Carmichael PA, Barnicoat A, Honour JW, Larcher V, Achermann JC. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab 2010; 24: 335-354
- 11 Schonbucher V, Schweizer K, Rustige L, Schtzmann K, Brunner F, Richter-Appelt H. Sexual quality of life of individuals with 46,XY disorders of sex development. J Sex Med 2012; 9: 3154-3170
- 12 Ozbaran B, Ozen S, Goksen D, Korkmaz O, Onay H, Ozkinay F, Cogulu O, Erermis S, Kose S, Avanoglu A, Ulman I, Darcan S. Psychiatric approaches for disroders of sex development: experience of a multidisciplinary team. J Clin Res Pediatr Endocrinol 2013; 5: 229-235
- 13 Jurgensen M, Lux A, Wien SB, Kleinemeier E, Hiort O, Thyen U. Health-related quality of life in children with disorders of sex development (DSD). Eur J Pediatr 2014; 173: 893-903
- 14 Cassia Amaral R, Inacio M, Brito VN, Bachega TA, Oliveira Jr AA, Domenice S, Denes FT, Sircili MH, Arnhold IJ, Madureira G, Gomes L, Costa EM, Mendonca BB. Quality of life in a large cohort of adult Brazilian patients with 46,XX and 46,XY disorders of sex development from a single tertiary centre. Clin Endocrinol 2015; 82: 274-279
- 15 Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int 2000; 85: 120-124
- 16 Lek N, Miles H, Bunch T, Pilford-Wilkie V, Tadokoro-Cuccaro R, Davies J, Ong KK, Hughes IA. Low frequency of androgen receptor gene mutations in 46 XY DSD and fetal growth restriction. Arch Dis Child 2014; 99: 358-361
- 17 Baxter RM, Arboleda VA, Lee H, Barseghyan H, Adam MP, Fechner PY, Bargman R, Keegan C, Travers S, Schelley S, Hudgins L, Mathew RP, Stalker HJ, Zori R, Gordon OK, Ramos-Platt L, Pawlikowska-Haddal A, Eskin A, Nelson SF, Delot E, Vilain E. Exome sequencing for the diagnosis of 46,XY disorders of sex development. J Clin Endocrinol Metab 2015; 100: E333-E344
- 18 Kolesinska Z, Ahmed SF, Niedziela M, Bryce J, Molinska-Glura M, Rodie M, Jiang J, Sinnott RO, Hughes IA, Darendeliler F, Hiort O, van der Zwan Y, Cools M, Guran T, Holterhus PM, Bertelloni S, Lisa L, Arlt W, Krone N, Ellaithi M, Balsamo A, Mazan A, Mazen I, Nordenstrom A, Lachlan K, Alkhawari M, Chatelain P, Weintob N. Changes over time in sex assignment for disorders of sex development. Pediatrics 2014; 134: e710-e715
- 19 Creighton S, Chernausek SD, Romao R, Ransley P, Salle JP. Timing and nature of reconstructive surgery for disorders of sex development-introduction. J Pediatr Urol 2012; 8: 602-610
- 20 Diamond M, Garland J. Evidence regarding cosmetic and medically unnecessary surgery on infants. J Pediatr Urol 2014; 10: 2-7
- 21 Mouriquand P, Caldamone A, Malone P, Frank JD, Hoebeke P. The ESPU/SPU standpoint on the surgical management of disorders of sex development (DSD). J Pediatr Urol 2014; 10: 8-10
- 22 Tamar-Mattis JD. Patient advocate response to DSD surgery debate. J Pediatr Urol 2014; 10: 788-789
- 23 Liao L-M, Audi L, Magritte E, Meyer-Bahlburg HFL, Quigley CA. Determinant factors of gender identity: a commentary. J Pediatr Urol 2012; 8: 597-601
- 24 Chuang J, Vallerie A, Breech L, Saal HM, Alam S, Crawford P, Rutter MM. Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early gonadectomy?. Int J Ped Endocrinol 2013; 2013: 15
- 25 Pasterski V, Zucker KJ, Hindmarsh PC, Hughes IA, Acerini C, Spencer D, Neufeld S, Hines M. Increased cross-gender identification independent of gender role behvior in girls with congenital adrenal hyperplasia: results from a standardized assessment of 4- to11-year-old children. Arch Sex Behav 2014; Sept 20 [Epub ahead of print]
- 26 van der Zwan YG, Biermann K, Wolffenbuttel KP, Cools M, Looijenga LH. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. Eur Urol. 2014 Sep 17 [Epub ahead of print]
- 27 Warne GL, Raza J. Disorders of sex development (DSDs), their presentation and management in different cultures. Rev Endocr Metab Disord 2008; 9: 227-236
- 28 Raza J, Mazen I. Achieving diagnostic certainty in resource-limited settings. Endocr Dev 2014; 27: 257-267
- 29 Pasterski V, Mastrotannopoulou K, Wright D, Zucker KJ, Hughes IA. Predictors of posttraumatic stress in parents of children diagnosed with a disorder of sex development. Arch Sex Behav 2014; 43: 369-375
- 30 Baratz AB, Sharp MK, Sandberg DE. Disorders of sex development peer support. Endocr Dev 2014; 27: 99-112
- 31 Nordenstrom A, Thyen U. Improving the communication of healthcare professionals with affected children and adolescents. Endocr Dev 2014; 27: 113-127
- 32 Tadokoro-Cuccaro R, Hughes IA. Androgen insensitivity syndrome. Curr Opin Endocrinol Diabetes Obes 2014; 21: 499-503
- 33 Hiort O, Birnbaum W, Marshall L, Wunsch L, Werner R, Schroder T, Dohnert U, Holterhus PM. Management of disorders of sex development. Nat Rev Endocrinol 2014; 10: 520-529